Arcutis Biotherapeutics, Inc.

Healthcare · Biotechnology · United States

Last price 31.97 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 4.02B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company’s lead product is ZORYVE, a topical roflumilast cream for the treatment of plaque psoriasis and atopic dermatitis. It also develops ZORYVE foam seborrheic dermatitis, and scalp and body psoriasis treatment; ARQ-234, a fusion protein that is a potent and highly selective checkpoint agonist of the CD200 receptor. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Bio...